Clinical Trial Update: A Clinical Trial of Fluvoxamine for Melancholia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating fluvoxamine for melancholia in depressive/endogenous depression conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Endogenous Depression
• Melancholia

Drugs mentioned

• Fluvoxamine (fluvoxamine)

Snippet

Sponsor: Lingjiang Li | Conditions: Depressive Disorder, Endogenous Depression | Phase 2 | Status: UNKNOWN